The purpose of this study is to find the highest dose of the investigational drug AM0010 that can be given safely in patients with metastatic melanoma, prostate cancer, ovarian cancer, kidney cancer, colorectal cancer, lung cancer, and pancreatic cancer.
AM0010 works by stimulating the immune system to fight cancer. It is a manmade version of a natural immune protein called interleukin-10 (IL-10), which is involved in regulating the immune system and inflammation in the body. It is hoped that AM0010 can trigger an immune response against cancer cells.
AM0010 is given as a daily injection under the skin.